ArticleClinical and translational medicine2024
STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.
Alexandra Fauvre et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.